Method for preparing component in spikemoss for reducing blood sugar and regulating blood fat and novel use thereof

A technology of Selaginella and macroporous resin columns, which is applied in the field of medicine and can solve the problem of not being able to determine what the active ingredient is
CN101485696AInactive Publication Date: 2009-07-22赵全成
3 Cites 6 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
赵全成
Publication Date
2009-07-22
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to high-content S.tamariscina(beav.)spring total flavonoids and a high-purity amentotaxus argotaenia biflavone monomer composition firstly prepared from Selaginella S.pvlvinata(Hook.et Gev.)Maxim, S.tamariscina(beav.) spring and S.moellendorfii Hieron by a macroporous resin and polyamide serial columns in series chromatography method. The S.tamariscina(beav.)spring total flavonoids and the amentotaxus argotaenia biflavone monomer composition are firstly proved to have functions of inhibiting alpha-glucosaccharase, reducing blood sugar, and regulating blood fat, and the S.tamariscina(beav.)spring total flavonoids and amentotaxus argotaenia biflavone in preventing have new application in treating hyperglycemia and hyperlipemia.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a new application of Selaginella, that is, total flavonoids of Selaginella and biflavone monomer components of Selaginella can be obtained through solvent extraction, separation and purification of Selaginella macroporous resin and polyamide series column chromatography. To be exact, it is the application of the total flavonoids of Selaginella extracted from Selaginella selaginella and the biflavonoids monomer components of Spicy chinensis in the preparation of hypoglycemic (α-glucosidase inhibitor) and blood lipid regulation. Pharmaceutical formulations of the drug are also involved. It belongs to the field of medical technology. Background technique

[0002] Dried whole of Selaginella Selaginella (Selaginella) Selaginella Selaginella (Hook. et Gev.) Maxim, S. tamariscina (beav.) spring and Selaginella Hieron Grass. Selaginella plants have anti-cancer, anti-inflammation, anti-virus, analgesic, hypotensive, hypoglycemic, ant...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More